Contact us


Chancellor's Fellowships

Building on the outstanding successes of our previous tenure-track Chancellor’s Fellowship programmes and our world class research performance, the College of Science & Engineering is investing in a further cohort of 10 next generation research innovation leaders of the highest quality with a particular focus on:

Virtual Reality Drug Design

Research by the Michel group and Interactive Scientific Limited has created new virtual reality software that could enhance drug design.

The technique uses molecular simulation software developed by the Michel group, in conjunction with visualisation using Interactive Scientific Limited's Nano Simbox. Combining the two pieces of software allows researchers to better visualise and understand the complex structures of proteins. This, in turn, could lead to a reduction in the time and money required to bring a new drug to market.

Poster Prize for Student

Congratulations to Giulia Novelli, a 1st year PhD student in the Parsons group, who has been awarded a poster prize in the IUCr Journals Applied Crystallography category at the European Crystallographic Meeting in Oviedo last week for her poster "Carbon Molecules in Space: a Thermal Equation of State Study of Solid Hexamethylenetetramine."

Young Investigator Distinction

Congratulations to Dr Andrew Lawrence and Dr Stephen Thomas, who have both received the Young Investigator Distinction award by the RSC and BMOS (Brazilian Meeting on Organic Synthesis).

The award recognizes and celebrates the achievements of these young investigators in advancing the chemical science and making a positive impact in their organizations, communities and society with independence and research originality/impact.

Scientists Unravel Molecular Mechanisms of Parkinson’s Disease

Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson’s disease. 

The study, published in Nature Communications, adds to our growing understanding of the causes of Parkinson’s and other neurodegenerative diseases, and could influence drug design in the future. The work was carried out by a team of scientists, including Dr Mathew Horrocks.